Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 2, Pages 260
Publisher
MDPI AG
Online
2019-02-23
DOI
10.3390/cancers11020260
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients
- (2019) Friederike Christen et al. BLOOD
- Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia
- (2019) Dyantha I. van der Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- IDH1-R132 changes vary according to NPM1 and other mutations status in AML
- (2019) Brunangelo Falini et al. LEUKEMIA
- Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells
- (2019) Warren Fiskus et al. Blood Cancer Journal
- Genetic Biomarkers Of Sensitivity and Resistance to Venetoclax Monotherapy in Patients With Relapsed Acute Myeloid Leukemia
- (2018) Brenda Chyla et al. AMERICAN JOURNAL OF HEMATOLOGY
- Apoptosis and Clearance of Apoptotic Cells
- (2018) Shigekazu Nagata Annual Review of Immunology
- Q482H mutation of procaspase-8 in acute myeloid leukemia abolishes caspase-8-mediated apoptosis by impairing procaspase-8 dimerization
- (2018) Ming Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Applications of metabolomics to study cancer metabolism
- (2018) Akash K. Kaushik et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Glucose-dependent growth arrest of leukemia cells by MCT1 inhibition: Feeding Warburg’s sweet tooth and blocking acid export as an anticancer strategy
- (2018) Aleksandra I. Pivovarova et al. BIOMEDICINE & PHARMACOTHERAPY
- Glutaminolysis is a metabolic dependency in FLT3ITDacute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition
- (2018) Paolo Gallipoli et al. BLOOD
- Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML
- (2018) Ronan T. Swords et al. BLOOD
- Prognostic factors influencing survival after allogeneic transplantation for AML/MDS patients withTP53mutations
- (2018) Stefan O. Ciurea et al. BLOOD
- PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells
- (2018) Josephine D. Kahn et al. BLOOD
- Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
- (2018) Gerrit J. Schuurhuis et al. BLOOD
- Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment
- (2018) Juliane M. Stosch et al. BRITISH JOURNAL OF HAEMATOLOGY
- Biological Role and Therapeutic Potential of IDH Mutations in Cancer
- (2018) Matthew S. Waitkus et al. CANCER CELL
- The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation
- (2018) Isabella Faraoni et al. CANCER LETTERS
- A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic LeukemiasIn Vivo
- (2018) Hien Anh Nguyen et al. CANCER RESEARCH
- Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells
- (2018) Mohamed Rahmani et al. CANCER RESEARCH
- Single agent and synergistic combinatorial efficacy of first-in-class small molecule imipridone ONC201 in hematological malignancies
- (2018) Varun V. Prabhu et al. CELL CYCLE
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies
- (2018) Robert L. Bowman et al. Cell Stem Cell
- AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells
- (2018) Shanshan Pei et al. Cell Stem Cell
- A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
- (2018) Timothy S. Pardee et al. CLINICAL CANCER RESEARCH
- Targeting the IDH2 Pathway in Acute Myeloid Leukemia
- (2018) Maria L. Amaya et al. CLINICAL CANCER RESEARCH
- Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
- (2018) Thomas M. Ashton et al. CLINICAL CANCER RESEARCH
- IAP Proteins Antagonist: An Introduction and Chemistry of Smac Mimetics under Clinical Development
- (2018) Rafat Ali et al. CURRENT MEDICINAL CHEMISTRY
- Branched-chain amino acid metabolism in cancer
- (2018) Elitsa A. Ananieva et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Recent Development of Small Molecule Glutaminase Inhibitors
- (2018) Minsoo Song et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents
- (2018) Yichao Wan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia
- (2018) Mark A. Gregory et al. EXPERIMENTAL HEMATOLOGY
- FLIP as a therapeutic target in cancer
- (2018) Luke Humphreys et al. FEBS Journal
- Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
- (2018) Ibrahim Aldoss et al. HAEMATOLOGICA
- Pharmacologic inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells
- (2018) Dang Wu et al. HAEMATOLOGICA
- Dexamethasone in hyperleukocytic acute myeloid leukemia
- (2018) Sarah Bertoli et al. HAEMATOLOGICA
- Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged ≥ 75 years
- (2018) Victoria V. Prassek et al. HAEMATOLOGICA
- Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation
- (2018) Olivier Micheau INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment
- (2018) Jessica Wagner et al. JOURNAL OF CLINICAL INVESTIGATION
- CDK9 inhibitors in acute myeloid leukemia
- (2018) Silvia Boffo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- BCL-2 as therapeutic target for hematological malignancies
- (2018) Guilherme Fleury Perini et al. Journal of Hematology & Oncology
- Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors
- (2018) Stefano Sainas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
- (2018) Courtney D DiNardo et al. LANCET ONCOLOGY
- RET-mediated autophagy suppression as targetable co-dependence in acute myeloid leukemia
- (2018) S. Rudat et al. LEUKEMIA
- IDH1R132, IDH2R140 and IDH2R172 in AML: different genetic landscapes correlate with outcome and may influence targeted treatment strategies
- (2018) Manja Meggendorfer et al. LEUKEMIA
- Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies
- (2018) Ann-Kathrin Eisfeld et al. LEUKEMIA
- Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion
- (2018) William L. Heaton et al. LEUKEMIA
- Consequences of mutant TET2 on clonality and subclonal hierarchy
- (2018) Cassandra M. Hirsch et al. LEUKEMIA
- Chromothripsis in acute myeloid leukemia: biological features and impact on survival
- (2018) Maria Chiara Fontana et al. LEUKEMIA
- Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia
- (2018) Maja Rothenberg-Thurley et al. LEUKEMIA
- Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host
- (2018) Marlies Meisel et al. NATURE
- An inhibitor of oxidative phosphorylation exploits cancer vulnerability
- (2018) Jennifer R. Molina et al. NATURE MEDICINE
- Somatic mutations precede acute myeloid leukemia years before diagnosis
- (2018) Pinkal Desai et al. NATURE MEDICINE
- Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib
- (2018) Lynn Quek et al. NATURE MEDICINE
- Kinase inhibitors: the road ahead
- (2018) Fleur M. Ferguson et al. NATURE REVIEWS DRUG DISCOVERY
- Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
- (2018) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Minimal Residual Disease in Acute Myeloid Leukemia
- (2018) Mojca Jongen-Lavrencic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling
- (2018) Martin Grundy et al. PLoS One
- Iterative optimization yields Mcl-1–targeting stapled peptides with selective cytotoxicity to Mcl-1–dependent cancer cells
- (2018) Raheleh Rezaei Araghi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Statins enhance efficacy of venetoclax in blood cancers
- (2018) J. Scott Lee et al. Science Translational Medicine
- Mutations in the P10 region of procaspase-8 lead to chemotherapy resistance in acute myeloid leukemia by impairing procaspase-8 dimerization
- (2018) Ming Li et al. Cell Death & Disease
- Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential
- (2018) Terrence N. Wong et al. Nature Communications
- A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- (2018) Marcus J. G. W. Ladds et al. Nature Communications
- Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia
- (2018) Bradley Stockard et al. Scientific Reports
- PPM1K Regulates Hematopoiesis and Leukemogenesis through CDC20-Mediated Ubiquitination of MEIS1 and p21
- (2018) Xiaoye Liu et al. Cell Reports
- Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
- (2018) Ibrahim Aldoss et al. HAEMATOLOGICA
- Pharmacologic inhibition of dihydroorotate dehydrogenase induces apoptosis and differentiation in acute myeloid leukemia cells
- (2018) Dang Wu et al. HAEMATOLOGICA
- Dexamethasone in hyperleukocytic acute myeloid leukemia
- (2018) Sarah Bertoli et al. HAEMATOLOGICA
- Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged ≥ 75 years
- (2018) Victoria V. Prassek et al. HAEMATOLOGICA
- Role of Dopamine Receptors in the Anticancer Activity of ONC201
- (2018) Christina Leah B. Kline et al. NEOPLASIA
- p53-Autophagy-Metastasis Link
- (2018) Tatiana Denisenko et al. Cancers
- P53 protein overexpression in de novo acute myeloid leukemia patients with normal diploid karyotype correlates with FLT3 internal tandem duplication and worse relapse-free survival
- (2018) Rita Assi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Glutaminase isoenzymes in the metabolic therapy of cancer
- (2018) José M. Matés et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The role of XIAP in resistance to TNF-related apoptosis-inducing ligand (TRAIL) in Leukemia
- (2018) Raedeh Saraei et al. BIOMEDICINE & PHARMACOTHERAPY
- Mutant NPM1 Maintains the Leukemic State through HOX Expression
- (2018) Lorenzo Brunetti et al. CANCER CELL
- Identification of Chemotherapy-Induced Leukemic-Regenerating Cells Reveals a Transient Vulnerability of Human AML Recurrence
- (2018) Allison L. Boyd et al. CANCER CELL
- Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells
- (2018) Haobin Ye et al. CANCER CELL
- Abstract DDT02-04: BAY 2402234: A novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of myeloid malignancies
- (2018) Andreas Janzer et al. CANCER RESEARCH
- Abstract 1655: Discovery and development of IACS-010759, a novel inhibitor of Complex I currently in phase I studies to exploit oxidative phosphorylation dependency in acute myeloid leukemia and solid tumors
- (2018) Maria Emilia Di Francesco et al. CANCER RESEARCH
- Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models
- (2018) Waleed Minzel et al. CELL
- Combined BCL-2 and HDAC Targeting Has Potent and TP53 Independent Activity In AML
- (2018) Jessica Salmon et al. EXPERIMENTAL HEMATOLOGY
- High-throughput single-cell DNA sequencing of acute myeloid leukemia tumors with droplet microfluidics
- (2018) Maurizio Pellegrino et al. GENOME RESEARCH
- CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia
- (2018) Muhammed H. Rahaman et al. INVESTIGATIONAL NEW DRUGS
- Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates
- (2018) Xiaorong Gu et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of variant allele frequency of mutant PTPN11 in AML: Single institution experience of 122 patients.
- (2018) Mansour Alfayez et al. JOURNAL OF CLINICAL ONCOLOGY
- Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions
- (2018) Xi Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia
- (2018) Nicolas Duployez et al. LEUKEMIA
- Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia
- (2018) Donia M. Moujalled et al. LEUKEMIA
- Final results of a randomized multicenter phase II study of alvocidib, cytarabine, and mitoxantrone versus cytarabine and daunorubicin (7 + 3) in newly diagnosed high-risk acute myeloid leukemia (AML)
- (2018) Joshua F. Zeidner et al. LEUKEMIA RESEARCH
- Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
- (2018) Xiaotu Ma et al. NATURE
- The genetic basis and cell of origin of mixed phenotype acute leukaemia
- (2018) Thomas B. Alexander et al. NATURE
- Prediction of acute myeloid leukaemia risk in healthy individuals
- (2018) Sagi Abelson et al. NATURE
- Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations
- (2018) Andrew M. Intlekofer et al. NATURE
- Mutation Clearance after Transplantation for Myelodysplastic Syndrome
- (2018) Eric J. Duncavage et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response
- (2018) Akito Nakamura et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization and targeting of malignant stem cells in patients with advanced myelodysplastic syndromes
- (2018) Brett M. Stevens et al. Nature Communications
- A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways
- (2018) Indre Piragyte et al. Nature Communications
- A Novel MCL-1 Inhibitor Combined with Venetoclax Rescues Venetoclax Resistant Acute Myelogenous Leukemia
- (2018) Haley E. Ramsey et al. Cancer Discovery
- Characterization of Mutations in the Mitochondrial Encoded Electron Transport Chain Complexes in Acute Myeloid Leukemia
- (2018) Sharon Wu et al. Scientific Reports
- Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML
- (2018) Eimear O’ Reilly et al. Scientific Reports
- Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial
- (2018) Tapan M Kadia et al. Lancet Haematology
- Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy
- (2018) The Duy Nguyen et al. BLOOD
- Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib
- (2018) Eytan M. Stein et al. BLOOD
- Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
- (2018) Courtney L. Jones et al. CANCER CELL
- The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation
- (2018) Natalia Martinez-Soria et al. CANCER CELL
- Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice
- (2018) Natasha S. Anstee et al. CELL DEATH AND DIFFERENTIATION
- Mutant p53 as a guardian of the cancer cell
- (2018) Fiamma Mantovani et al. CELL DEATH AND DIFFERENTIATION
- Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells
- (2018) Martina Bajzikova et al. Cell Metabolism
- PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
- (2018) Joanne I. Hsu et al. Cell Stem Cell
- The emergence of dihydroorotate dehydrogenase (DHODH) as a therapeutic target in acute myeloid leukemia
- (2018) David B. Sykes EXPERT OPINION ON THERAPEUTIC TARGETS
- Stable Isotope Labeling Highlights Enhanced Fatty Acid and Lipid Metabolism in Human Acute Myeloid Leukemia
- (2018) Lucille Stuani et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial
- (2018) Uwe Platzbecker et al. LANCET ONCOLOGY
- Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML
- (2018) Lina Benajiba et al. LEUKEMIA
- Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties
- (2018) Liangxian Cao et al. MOLECULAR CANCER THERAPEUTICS
- Functional genomic landscape of acute myeloid leukaemia
- (2018) Jeffrey W. Tyner et al. NATURE
- Subtype-specific regulatory network rewiring in acute myeloid leukemia
- (2018) Salam A. Assi et al. NATURE GENETICS
- Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
- (2018) Daniel A. Pollyea et al. NATURE MEDICINE
- Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
- (2018) Jiahao Chen et al. NATURE MEDICINE
- Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias
- (2018) Shahzya Chaudhury et al. Nature Communications
- Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition
- (2018) James J. Harding et al. Cancer Discovery
- Inhibition of FAO in AML co-cultured with BM adipocytes: mechanisms of survival and chemosensitization to cytarabine
- (2018) Yoko Tabe et al. Scientific Reports
- Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
- (2018) Don Benjamin et al. Cell Reports
- Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome
- (2017) Naval Daver et al. HAEMATOLOGICA
- Caspase-8: regulating life and death
- (2017) Bart Tummers et al. IMMUNOLOGICAL REVIEWS
- Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse
- (2017) Brian Parkin et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia
- (2017) Emilia L. Lim et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
- (2017) Lars Bullinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
- (2017) Christopher J. Gibson et al. JOURNAL OF CLINICAL ONCOLOGY
- Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1
- (2017) T-C Teh et al. LEUKEMIA
- RSK2 is a new Pim2 target with pro-survival functions in FLT3-ITD-positive acute myeloid leukemia
- (2017) M-A Hospital et al. LEUKEMIA
- The clonal origins of leukemic progression of myelodysplasia
- (2017) T Kim et al. LEUKEMIA
- ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition
- (2017) H-Q Ju et al. LEUKEMIA
- High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells
- (2017) L Poulain et al. LEUKEMIA
- Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target
- (2017) A Etxabe et al. LEUKEMIA
- X-linked inhibitor of apoptosis inhibition sensitizes acute myeloid leukemia cell response to TRAIL and chemotherapy through potentiated induction of proapoptotic machinery
- (2017) Jianbiao Zhou et al. Molecular Oncology
- Autophagy maintains the metabolism and function of young and old stem cells
- (2017) Theodore T. Ho et al. NATURE
- Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia
- (2017) Ayuna Hattori et al. NATURE
- BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
- (2017) Simon Raffel et al. NATURE
- Tracing the origins of relapse in acute myeloid leukaemia to stem cells
- (2017) Liran I. Shlush et al. NATURE
- Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
- (2017) Elodie M Kuntz et al. NATURE MEDICINE
- The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
- (2017) Hamid Bolouri et al. NATURE MEDICINE
- The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia
- (2017) Nina Fenouille et al. NATURE MEDICINE
- Decitabine in TP53-Mutated AML
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
- (2017) Richard M. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic FLT3-ITD supports autophagy via ATF4 in acute myeloid leukemia
- (2017) Q Heydt et al. ONCOGENE
- Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies
- (2017) Stephen E. Kurtz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overcoming mutational complexity in acute myeloid leukemia by inhibition of critical pathways
- (2017) Yoriko Saito et al. Science Translational Medicine
- Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysis
- (2017) Rui Huang et al. OncoTargets and Therapy
- Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia
- (2017) Hendrik Folkerts et al. Cell Death & Disease
- Dendrogenin A drives LXR to trigger lethal autophagy in cancers
- (2017) Gregory Segala et al. Nature Communications
- Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism
- (2017) Thomas Farge et al. Cancer Discovery
- Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase
- (2017) Salvatore Nicola Bertuccio et al. Oncotarget
- Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells
- (2017) Filipa Lopes-Coelho et al. Oncotarget
- Voruciclib, a clinical stage oral CDK9 inhibitor, represses MCL-1 and sensitizes high-risk Diffuse Large B-cell Lymphoma to BCL2 inhibition
- (2017) Joyoti Dey et al. Scientific Reports
- Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome
- (2017) Naval Daver et al. HAEMATOLOGICA
- A Phase II Study of Arginine Deiminase (ADI-PEG20) in Relapsed/Refractory or Poor-Risk Acute Myeloid Leukemia Patients
- (2017) Hui-Jen Tsai et al. Scientific Reports
- iBH3: simple, fixable BH3 profiling to determine apoptotic priming in primary tissue by flow cytometry
- (2016) Jeremy Ryan et al. BIOLOGICAL CHEMISTRY
- Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML
- (2016) Mohammed Dany et al. BLOOD
- Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia
- (2016) S. Piya et al. BLOOD
- Autophagy, a key mechanism of oncogenesis and resistance in leukemia
- (2016) Patrick Auberger et al. BLOOD
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia
- (2016) Jason A. Powell et al. BLOOD
- Evolution of acute myelogenous leukemia stem cell properties after treatment and progression
- (2016) T.-C. Ho et al. BLOOD
- Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
- (2016) K. H. Metzeler et al. BLOOD
- TP53mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes
- (2016) Tapan M. Kadia et al. CANCER
- Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential
- (2016) Wen-Lian Chen et al. CANCER CELL
- Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia
- (2016) David B. Sykes et al. CELL
- Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways
- (2016) Adeeb Derakhshan et al. CLINICAL CANCER RESEARCH
- The Autophagy Machinery Controls Cell Death Switching between Apoptosis and Necroptosis
- (2016) Megan L. Goodall et al. DEVELOPMENTAL CELL
- Oxidative stress and hypoxia in normal and leukemic stem cells
- (2016) Ugo Testa et al. EXPERIMENTAL HEMATOLOGY
- Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia
- (2016) Patrick D. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetically distinct leukemic stem cells in human CD34−acute myeloid leukemia are arrested at a hemopoietic precursor-like stage
- (2016) Lynn Quek et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasms
- (2016) V Visconte et al. LEUKEMIA
- HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
- (2016) M Kontro et al. LEUKEMIA
- CXCL12 promotes glycolytic reprogramming in acute myeloid leukemia cells via the CXCR4/mTOR axis
- (2016) M Braun et al. LEUKEMIA
- p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status
- (2016) A Quintás-Cardama et al. LEUKEMIA
- Subtype-specific patterns of molecular mutations in acute myeloid leukemia
- (2016) D Rose et al. LEUKEMIA
- Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia
- (2016) A-K Eisfeld et al. LEUKEMIA
- Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy
- (2016) G L Uy et al. LEUKEMIA
- The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
- (2016) A Stengel et al. LEUKEMIA
- Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis
- (2016) F Thol et al. LEUKEMIA
- PHD3 Loss in Cancer Enables Metabolic Reliance on Fatty Acid Oxidation via Deactivation of ACC2
- (2016) Natalie J. German et al. MOLECULAR CELL
- Co-operative and Hierarchical Binding of c-FLIP and Caspase-8: A Unified Model Defines How c-FLIP Isoforms Differentially Control Cell Fate
- (2016) Michelle A. Hughes et al. MOLECULAR CELL
- Cryo-EM Structure of Caspase-8 Tandem DED Filament Reveals Assembly and Regulation Mechanisms of the Death-Inducing Signaling Complex
- (2016) Tian-Min Fu et al. MOLECULAR CELL
- Mitochondria—Judges and Executioners of Cell Death Sentences
- (2016) Patrick D. Bhola et al. MOLECULAR CELL
- Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition
- (2016) Marco Sciacovelli et al. NATURE
- The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models
- (2016) András Kotschy et al. NATURE
- A 17-gene stemness score for rapid determination of risk in acute leukaemia
- (2016) Stanley W. K. Ng et al. NATURE
- The genomic landscape of core-binding factor acute myeloid leukemias
- (2016) Zachary J Faber et al. NATURE GENETICS
- Dynamics of clonal evolution in myelodysplastic syndromes
- (2016) Hideki Makishima et al. NATURE GENETICS
- Assessment of Minimal Residual Disease in Standard-Risk AML
- (2016) Adam Ivey et al. NEW ENGLAND JOURNAL OF MEDICINE
- TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
- (2016) John S. Welch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells
- (2016) C Safferthal et al. ONCOGENE
- ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia
- (2016) Mark A. Gregory et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases
- (2016) C. Leah B. Kline et al. Science Signaling
- ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies
- (2016) Jo Ishizawa et al. Science Signaling
- The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia
- (2016) Gabriela Brumatti et al. Science Translational Medicine
- Development of ML390: A Human DHODH Inhibitor That Induces Differentiation in Acute Myeloid Leukemia
- (2016) Timothy A. Lewis et al. ACS Medicinal Chemistry Letters
- ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation
- (2016) Luise Hartmann et al. Nature Communications
- Blastic Plasmacytoid Dendritic Cell Neoplasm Is Dependent on BCL2 and Sensitive to Venetoclax
- (2016) Joan Montero et al. Cancer Discovery
- Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
- (2016) M. Konopleva et al. Cancer Discovery
- Complementary dynamic BH3 profiles predict co-operativity between the multi-kinase inhibitor TG02 and the BH3 mimetic ABT-199 in acute myeloid leukaemia cells
- (2016) Monica Pallis et al. Oncotarget
- Smac mimetic induces cell death in a large proportion of primary acute myeloid leukemia samples, which correlates with defined molecular markers
- (2016) Sonja C. Lueck et al. Oncotarget
- Discovery and clinical introduction of first-in-class imipridone ONC201
- (2016) Joshua E. Allen et al. Oncotarget
- Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
- (2016) Polina Matre et al. Oncotarget
- ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2α kinases
- (2016) C. Leah B. Kline et al. Science Signaling
- ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies
- (2016) Jo Ishizawa et al. Science Signaling
- High Expression of CPT1A Predicts Adverse Outcomes: A Potential Therapeutic Target for Acute Myeloid Leukemia
- (2016) Jinlong Shi et al. EBioMedicine
- Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target
- (2015) F. Mussai et al. BLOOD
- Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias
- (2015) M. R. Ricciardi et al. BLOOD
- International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
- (2015) H. Dombret et al. BLOOD
- Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
- (2015) N. Jacque et al. BLOOD
- Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo
- (2015) F. Miraki-Moud et al. BLOOD
- The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia
- (2015) A. Baker et al. CANCER RESEARCH
- Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
- (2015) Joan Montero et al. CELL
- The BCL-2 protein family, BH3-mimetics and cancer therapy
- (2015) A R D Delbridge et al. CELL DEATH AND DIFFERENTIATION
- AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow
- (2015) Yusuke Saito et al. Cell Stem Cell
- Negative regulation of the LKB1/AMPK pathway by ERK in human acute myeloid leukemia cells
- (2015) Ichiro Kawashima et al. EXPERIMENTAL HEMATOLOGY
- Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia
- (2015) J. F. Zeidner et al. HAEMATOLOGICA
- Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes
- (2015) Tuomas Laukka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia
- (2015) R Sood et al. LEUKEMIA
- Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients
- (2015) S Jilg et al. LEUKEMIA
- Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway
- (2015) Joshua E Allen et al. Molecular Cancer
- Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
- (2015) Jan Krönke et al. NATURE
- Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia
- (2015) Steven M Chan et al. NATURE MEDICINE
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-cell genotyping demonstrates complex clonal diversity in acute myeloid leukemia
- (2015) Amy L. Paguirigan et al. Science Translational Medicine
- Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)
- (2015) J D Leverson et al. Cell Death & Disease
- TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution
- (2015) H-A Hou et al. Blood Cancer Journal
- Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia
- (2015) Pierre Sujobert et al. Cell Reports
- Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia
- (2015) J. F. Zeidner et al. HAEMATOLOGICA
- Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs
- (2015) Jo Ishizawa et al. PLoS One
- XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells
- (2015) Daniel Moreno-Martínez et al. Oncotarget
- The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells
- (2014) W. K. Chan et al. BLOOD
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutations
- (2014) R. C. Lindsley et al. BLOOD
- A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value
- (2014) W.-L. Chen et al. BLOOD
- Maritoclax induces apoptosis in acute myeloid leukemia cells with elevated Mcl-1 expression
- (2014) Kenichiro Doi et al. CANCER BIOLOGY & THERAPY
- Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia
- (2014) Jeffery M. Klco et al. CANCER CELL
- Importance of Glutamine Metabolism in Leukemia Cells by Energy Production Through TCA Cycle and by Redox Homeostasis
- (2014) Mineaki Goto et al. CANCER INVESTIGATION
- Cell-State-Specific Metabolic Dependency in Hematopoiesis and Leukemogenesis
- (2014) Ying-Hua Wang et al. CELL
- Embelin Sensitizes Acute Myeloid Leukemia Cells to TRAIL through XIAP Inhibition and NF-κB Inactivation
- (2014) Tianxin Yang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies
- (2014) T. S. Pardee et al. CLINICAL CANCER RESEARCH
- Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML
- (2014) Andrew Volk et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies
- (2014) J M Bogenberger et al. LEUKEMIA
- Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia
- (2014) Liran I. Shlush et al. NATURE
- Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
- (2014) Terrence N. Wong et al. NATURE
- Identification of Novel Molecular Markers for Prognosis Estimation of Acute Myeloid Leukemia: Over-Expression of PDCD7, FIS1 and Ang2 May Indicate Poor Prognosis in Pretreatment Patients with Acute Myeloid Leukemia
- (2014) Yiming Tian et al. PLoS One
- Inhibition of mTOR-Dependent Autophagy Sensitizes Leukemic Cells to Cytarabine-Induced Apoptotic Death
- (2014) Mihajlo Bosnjak et al. PLoS One
- Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission
- (2014) M. R. Corces-Zimmerman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Necroptosis in health and diseases
- (2014) Wen Zhou et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Autophagy Controls the Kinetics and Extent of Mitochondrial Apoptosis by Regulating PUMA Levels
- (2014) Jacqueline Thorburn et al. Cell Reports
- Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
- (2013) F. Mussai et al. BLOOD
- Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia
- (2013) L. Willems et al. BLOOD
- Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling
- (2013) P. S. Hole et al. BLOOD
- Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9
- (2013) Jacqueline L.Y. Chee et al. CELL CYCLE
- BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
- (2013) Eleni D. Lagadinou et al. Cell Stem Cell
- Inhibition of glutaminase selectively suppresses the growth of primary acute myeloid leukemia cells with IDH mutations
- (2013) Ashkan Emadi et al. EXPERIMENTAL HEMATOLOGY
- A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo
- (2013) F. Abulwerdi et al. MOLECULAR CANCER THERAPEUTICS
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Genomic Landscapes and Clonality of De Novo AML
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Dual Inactivation of Akt and ERK by TIC10 Signals Foxo3a Nuclear Translocation, TRAIL Gene Induction, and Potent Antitumor Effects
- (2013) J. E. Allen et al. Science Translational Medicine
- Mechanisms of Action of Bcl-2 Family Proteins
- (2013) A. Shamas-Din et al. Cold Spring Harbor Perspectives in Biology
- Concomitant inhibition of DNA methyltransferase and BCL-2 protein function synergistically induce mitochondrial apoptosis in acute myelogenous leukemia cells
- (2012) Twee Tsao et al. ANNALS OF HEMATOLOGY
- Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML
- (2012) Thanh-Trang Vo et al. CELL
- Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia
- (2012) S. P. Glaser et al. GENES & DEVELOPMENT
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
- (2012) Li Ding et al. NATURE
- A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance
- (2012) Keisuke Ito et al. NATURE MEDICINE
- Clonal Architecture of Secondary Acute Myeloid Leukemia
- (2012) Matthew J. Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atg7 Modulates p53 Activity to Regulate Cell Cycle and Survival During Metabolic Stress
- (2012) I. H. Lee et al. SCIENCE
- Metabolomics for mitochondrial and cancer studies
- (2011) Deepak Nagrath et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutations
- (2011) Roberta Riccioni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Wild-type and mutant p53 proteins interact with mitochondrial caspase-3
- (2011) Amanda K. Frank et al. CANCER BIOLOGY & THERAPY
- Addition of AEG35156 XIAP Antisense Oligonucleotide in Reinduction Chemotherapy Does Not Improve Remission Rates in Patients With Primary Refractory Acute Myeloid Leukemia in a Randomized Phase II Study
- (2011) Aaron D. Schimmer et al. Clinical Lymphoma Myeloma & Leukemia
- The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance
- (2011) Monika Mortensen et al. JOURNAL OF EXPERIMENTAL MEDICINE
- High TRAIL-R3 expression on leukemic blasts is associated with poor outcome and induces apoptosis-resistance which can be overcome by targeting TRAIL-R2
- (2011) M.E.D. Chamuleau et al. LEUKEMIA RESEARCH
- The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation
- (2010) A. S. Green et al. BLOOD
- FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells
- (2010) F. Liu et al. BLOOD
- Inhibition of Glutaminase Preferentially Slows Growth of Glioma Cells with Mutant IDH1
- (2010) M. J. Seltzer et al. CANCER RESEARCH
- Mcl1 haploinsufficiency protects mice from Myc-induced acute myeloid leukemia
- (2010) Zhifu Xiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Erratum: Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
- (2010) Lenny Dang et al. NATURE
- Heightened mitochondrial priming is the basis for apoptotic hypersensitivity of CD4+ CD8+ thymocytes
- (2010) J. A. Ryan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway
- (2010) A. A. Khutornenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation
- (2009) G. Yoshimoto et al. BLOOD
- Clinical Applications of Metabolomics in Oncology: A Review
- (2009) J. L. Spratlin et al. CLINICAL CANCER RESEARCH
- Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
- (2009) Ismael Samudio et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I/II Trial of AEG35156 X-Linked Inhibitor of Apoptosis Protein Antisense Oligonucleotide Combined With Idarubicin and Cytarabine in Patients With Relapsed or Primary Refractory Acute Myeloid Leukemia
- (2009) Aaron D. Schimmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Phorbol ester-induced PKC down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation
- (2008) G. Gobbi et al. BLOOD
- Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5
- (2008) B. Z. Carter et al. BLOOD
- Synergistic Proapoptotic Activity of Recombinant TRAIL Plus the Akt Inhibitor Perifosine in Acute Myelogenous Leukemia Cells
- (2008) P. L. Tazzari et al. CANCER RESEARCH
- PPARδ is a ligand-dependent negative regulator of vitamin D3-induced monocyte differentiation
- (2008) Athina Lymboussaki et al. CARCINOGENESIS
- p53 Target Genes Sestrin1 and Sestrin2 Connect Genotoxic Stress and mTOR Signaling
- (2008) Andrei V. Budanov et al. CELL
- Involvement of Protective Autophagy in TRAIL Resistance of Apoptosis-defective Tumor Cells
- (2008) Jie Han et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of autophagy by cytoplasmic p53
- (2008) Ezgi Tasdemir et al. NATURE CELL BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now